Functional significance of PMM2 mutations in mildly affected patients with congenital disorders of glycosylation Ia
Open Access
- 1 November 2001
- journal article
- case report
- Published by Elsevier in Genetics in Medicine
- Vol. 3 (6) , 393-398
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Congenital disorders of glycosylation: genetic model systems lead the wayTrends in Cell Biology, 2001
- Deficiency of dolichol-phosphate-mannose synthase-1 causes congenital disorder of glycosylation type IeJournal of Clinical Investigation, 2000
- Dolichol phosphate mannose synthase (DPM1) mutations define congenital disorder of glycosylation Ie (CDG-Ie)Journal of Clinical Investigation, 2000
- A novel carbohydrate-deficient glycoprotein syndrome characterized by a deficiency in glucosylation of the dolichol-linked oligosaccharide.Journal of Clinical Investigation, 1998
- Absence of homozygosity for predominant mutations in PMM2 in Danish patients with carbohydrate-deficient glycoprotein syndrome type 1European Journal of Human Genetics, 1998
- Intestinal, Pancreatic and Hepatic Involvement in Carbohydrate-Deficient Glycoprotein Syndrome Type IJournal of Pediatric Gastroenterology and Nutrition, 1998
- Carbohydrate-deficient glycoprotein syndrome type Ib. Phosphomannose isomerase deficiency and mannose therapy.Journal of Clinical Investigation, 1998
- Mutations in PMM2, a phosphomannomutase gene on chromosome 16p13 in carbohydrate-deficient glycoprotein type I syndrome (Jaeken syndrome)Nature Genetics, 1997
- Phosphomannomutase deficiency is a cause of carbohydrate‐deficient glycoprotein syndrome type IFEBS Letters, 1995
- Abnormal synthesis of dolichol-linked oligosaccharides in carbohydrate-deficient glycoprotein syndromeGlycobiology, 1995